Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of MET amplification on gastric cancer: Possible roles as a novel prognostic marker and a potential therapeutic target

18 Mar 2011

Abstract excerpt

Identification of critical genes which play pivotal roles in controlling tumor growth and survival will establish the basis for developing therapeutic targets. With the aim of establishing personalized medicine for treatment of solid tumors, we focused on MET amplification in gastric cancer patients, given the extreme sensitivity to c-Met inhibitor in MET amplified gastric cancer cell lines. We tested MET...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Liver physiology and pathology
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21424128
DOI: 10.3892/or.2011.1219

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of MET amplification on gastric cancer: Possible roles as a novel prognostic marker and a potential therapeutic targetPMID 21424128Read ↗

<i>MET</i> amplification as a potential therapeutic target in gastric cancerSemantic proximity Read ↗

Forty‐nine gastric cancer cell lines with integrative genomic profiling for development of c‐MET inhibitorSemantic proximity Read ↗

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcomeSemantic proximity Read ↗

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinomaSemantic proximity Read ↗

MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.Semantic proximity Read ↗

MET-amplified gastric cancers exhibit co-amplifications of BRAF, CDK6, and EGFR.Semantic proximity Read ↗

Gastric cancer patient with c-MET amplification treated with crizotinib after failed multi-line treatment: A case report and literature reviewSemantic proximity Read ↗

Amplification of <i>MET</i> may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752Semantic proximity Read ↗

Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.Semantic proximity Read ↗

Targeting MET Dysregulation in CancerSemantic proximity Read ↗

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Semantic proximity Read ↗

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.